使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主
Operator
Operator
Good morning and welcome to IM Cannabis Corp's first quarter 2025 earnings conference call. Today's conference call is being recorded.
早安,歡迎參加 IM Cannabis Corp 2025 年第一季財報電話會議。今天的電話會議將進行錄音。
At this time, I would like to turn the conference over to Anna Taranko, Director of Investor and Public Relations. Anna.
此刻,我想將會議交給投資人與公共關係總監 Anna Taranko。Anna。
Anna Taranko - Director Investor & Public Relations
Anna Taranko - Director Investor & Public Relations
Good morning and thank you operator. Joining me for today's call are IM Cannabis, Chief Executive Officer Oren Shuster and Chief Financial Officer, Uri Birenberg. The earnings and press release that accompanies this call is available on the investor relations section of our website at investors.i mcannabis.com.
早安,謝謝接線員。今天與我一同出席的有 IM Cannabis 執行長 Oren Shuster 以及財務長 Uri Birenberg。本次電話會議所對應的財報與新聞稿,可於我們網站的投資人關係專區 investors.i mcannabis.com 查閱。
Today's call will include estimates and other forward-looking information and statements, including statements concerning future results of operations, economic conditions and anticipated courses of action and are based on assumptions, expectations, estimates and projections as the date here.
今天的電話會議將包含估計及其他前瞻性資訊與陳述,包括關於未來營運結果、經濟狀況及預期行動方針的陳述,並係基於截至本日之假設、預期、估計與推測。
This information may involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied by such statements. Factors that could cause or contribute to such differences are described in detail in the company's most recent filings available on Cedars at www.cedarplus.ca and Edgar at www.sec.gov.
此等資訊可能涉及已知與未知之風險、不確定性及其他因素,可能導致實際結果與該等陳述所明示或暗示者有重大差異。可能造成或促成此等差異之因素,已於公司最新申報文件中詳述,該等文件可於 Cedars(www.cedarplus.ca)及 Edgar(www.sec.gov)查閱。
Furthermore, certain non-IFRS measures will be referred to during this call. The term non IFRS adjusted eit loss or non IFRS adjusted EBITDA will hereafter be referred to as adjusted EBITDA loss or adjusted EBITDA as applicable.
此外,本次電話會議將提及若干非 IFRS 衡量指標。「非 IFRS 調整後 EIT 損失」或「非 IFRS 調整後 EBITDA」之用語,以下將視情況分別稱為「調整後 EBITDA 損失」或「調整後 EBITDA」。
Any estimates or forward-looking information or statements provided are accurate only as of the date of this call, and the company undertakes no obligation to publicly update any forward-looking information or statements or supply new information regarding the circumstances after the date of this call. Please also note that all references on this call reflect currency in CAD unless otherwise stated. With that, it's my pleasure to turn the call over to Oren Shuster, CEO of IM Cannabis. Oren, please go ahead.
任何所提供之估計或前瞻性資訊或陳述,僅於本次電話會議日期當日為準;公司不承擔於本次電話會議日期後就情勢變化公開更新任何前瞻性資訊或陳述,或提供新資訊之義務。另請注意,除非另有說明,本次電話會議中所有金額均以加幣(CAD)表示。接下來,我很榮幸將電話會議交給 IM Cannabis 執行長 Oren Shuster。Oren,請開始。
Oren Shuster - Chairman, Chief Executive Officer
Oren Shuster - Chairman, Chief Executive Officer
Thank you, Good morning, everyone and thank you for joining us today.
謝謝。各位早安,感謝今天加入我們。
While presenting the 2024 full year results in March, I focused on the progress we made internally, both strategically and operationally. The efficiencies and integration to build a solid rights of foundation to deliver on in 2025.
在三月發表 2024 全年業績時,我著重於我們在內部所取得的進展,無論在策略面或營運面。透過效率提升與整合,建立穩固且正確的基礎,以在 2025 年交付成果。
In Q1 2025, we can see in the group's financial results that we have hit our target. In Q1, INC reached net profit with an 87% improvement in our gross margin versus Q1 2024. Our focus continues to be on execution. Shifting our resources to where we see the biggest ROI and leaning into our integrated structure.
在 2025 年第一季,從集團的財務結果可見我們已達成目標。第一季,IMC 實現淨利,且相較 2024 年第一季,我們的毛利率改善了 87%。我們的重點仍在於落實執行。將資源轉向我們看到投資報酬率(ROI)最高之處,並充分運用我們的整合式架構。
In Q1, with our integrated supply chain, we launched a total of 12 new strains in Germany, driving about â¬3 million or 39% of our cannabis flour sales in Germany.
第一季,憑藉我們整合的供應鏈,我們在德國推出共 12 個新品種,帶動德國大麻花(flower)銷售約 300 萬歐元,約占德國大麻花銷售的 39%。
To put this into perspective, in the second half of 2024, we imported a total of 11 new strains to Germany for an upside in sales of about 14% in Germany.
作為對照,2024 年下半年我們共向德國進口 11 個新品種,使德國銷售上升約 14%。
In Q1 of 2025 alone, we have already exceeded the last six months of 2024.
僅 2025 年第一季,我們就已超越 2024 年後六個月的表現。
Needless to say, I'm very proud of the work the entire team, both in Israel and in Germany, put in to deliver these results.
毋庸置疑,我對整個團隊在以色列與德國所投入的努力感到非常自豪,並成功交出這些成果。
Moving on to Israel, we see that the shifting focus and resources towards the German market and supply delays impacted our Israeli business.
接著談以色列,我們看到將重心與資源轉向德國市場,以及供應延遲,對以色列業務造成影響。
While the Israeli revenue declined by 56% versus Q1 2024, our German business grew 569% versus Q1 2024, offsetting the revenue decline in Israel.
雖然以色列營收較 2024 年第一季下滑 56%,但我們德國業務較 2024 年第一季成長 569%,抵銷了以色列的營收下滑。
In addition, we are seeing that the cost cutting measures produced by shifting our production facility in Israel in 2024 are flowing through to the financial results, leading to the increasing gross margin of 87% and an increase in gross profit of 94%.
此外,我們也看到 2024 年將以色列生產設施轉移所帶來的成本削減措施,已反映在財務結果中,使毛利率提升 87%,毛利增加 94%。
To sum up the first quarter of 2025, I'm delighted to see how the efficiencies and integration of the past two years is starting to be visible in our financial results.
總結 2025 年第一季,我很高興看到過去兩年效率提升與整合的成果,開始在我們的財務結果中顯現。
Our goal was for the group to be positive, which we achieved this quarter. Our target now is to continue to execute our strategy.
我們的目標是讓集團轉為正向,而本季已達成。我們現在的目標是持續落實執行我們的策略。
I will now end the call over to OA who will review our first quarter 2025 financial results.
接下來我將把電話會議交給 OA,由他回顧我們 2025 年第一季的財務結果。
Uri Birenberg - Chief Financial Officer
Uri Birenberg - Chief Financial Officer
Thank you, Owen.
謝謝你,Owen。
Before reviewing our Q1 results, I would like to emphasize one of these quarter milestones.
在檢視第一季業績之前,我想強調本季的一項里程碑。
The adjusted EBITDA in Q1 2025 resulted in a profit of 0.6 million compared to an adjusted debit loss of 2.2 million in Q1 2024, which is an improvement of almost 3 million. The company achieved a net profit of approximately 0.2 million.
2025 年第一季調整後 EBITDA 為獲利 60 萬,相較 2024 年第一季調整後 EBITDA 虧損 220 萬,改善近 300 萬。公司實現約 20 萬的淨利。
Our Q1 results were mainly impacted by the following points.
我們第一季的結果主要受到以下幾點影響。
The German region revenue in Q1 increased by 569% versus Q1 2024, and we continued with our expense reduction process, which resulted in a decrease in operating expenses of approximately 56% versus Q1 2024.
德國地區第一季營收較 2024 年第一季增加 569%,同時我們持續推動費用縮減流程,使營運費用較 2024 年第一季下降約 56%。
I will now take you through the overview of the Q1 2025 financial results for the company's operations. Revenues for Q1 2025 were 12.5 million compared to 12.1 million in Q1 2024, an increase of 0.4 million or 4%.
接下來我將帶各位概覽公司營運的 2025 年第一季財務結果。2025 年第一季營收為 1,250 萬,相較 2024 年第一季的 1,210 萬,增加 40 萬或 4%。
The increase is mainly attributed to the accelerated growth in Germany with an increasing revenue of 6.6 million and decreased revenue in Israel of 6.1 million net.
此增幅主要歸因於德國加速成長,營收增加 660 萬,以及以色列營收減少 610 萬(淨額)。
The decrease is attributed to the organin bill cancellation, which resulted in a decreasing in revenue of approximately 3.5 million compared to Q1 2024.
該減少歸因於 organin bill 取消,導致營收較 2024 年第一季減少約 350 萬。
Germany's share of total revenue in Q1 2025 has significantly increased compared to the corresponding period in 2024 to 62%.
2025 年第一季德國占總營收比重相較 2024 年同期顯著提高至 62%。
This increase has had a considerable impact, reflected in a higher average price due to a favorable market conditions and growing demand.
此一增加帶來相當大的影響,反映在平均售價較高,係因市場條件有利及需求成長。
The cost of revenue for Q1 2025 was 9.1 million compared to 10.3 million in Q1 2024, a decrease of 1.2 million or 12%. This is mainly due to the 0.6 million slow inventory clearing in Q1 2024 and other expenses decrease in Q1 2025 of about 0.6 million net.
2025 年第一季營收成本為 910 萬,相較 2024 年第一季的 1,030 萬,減少 120 萬或 12%。主要原因為 2024 年第一季有 60 萬的滯銷庫存清理,以及 2025 年第一季其他費用淨額減少約 60 萬。
Gross profit for Q1 2025 was 3.4 million compared to 1.8 million in Q1 2024, an increase of 1.6 million or 94%.
2025 年第一季毛利為 340 萬,相較於 2024 年第一季的 180 萬,增加 160 萬或 94%。
GNA expenses for Q1 2025 were 2 million compared to 2.3 million in Q1 2024, a decrease of 0.3 million or 14%.
2025 年第一季 GNA 費用為 200 萬,相較於 2024 年第一季的 230 萬,減少 30 萬或 14%。
Selling and marketing expenses for Q1 2025 were 1.3 million compared to 2.3 million in Q1 2024, a decrease of 1 million or 44%. The decrease is mainly attributed to our name revoked agreement of approximately 0.8 million.
2025 年第一季銷售與行銷費用為 130 萬,相較於 2024 年第一季的 230 萬,減少 100 萬或 44%。該下降主要歸因於我們約 80 萬的名稱撤銷協議。
Total operating expenses for Q1 2025 were 3.3 million compared to 7.4 million in Q1 2024, a decrease of 4.1 million or 56%.
2025 年第一季總營運費用為 330 萬,相較於 2024 年第一季的 740 萬,減少 410 萬或 56%。
Operating expenses ratio for Q1 2025 was 26% versus 77%, excluding the one-time expense outcome of a RMB cancellation for Q1 2024. Representing an increased efficiency of about 66%. The efficiency ratio improvement results from decreased operational cost and increased revenue.
2025 年第一季營運費用率為 26%,相較為 77%,並排除 2024 年第一季一次性費用(人民幣取消)之影響。代表效率提升約 66%。效率比率的改善來自營運成本下降與營收增加。
EBITDA for Q1 2025 was 0.6 million profit compared to loss of 5 million in Q1 2024, an increase of 5.6 million. Net profit for Q1 2025 was 0.2 million compared to loss of 6 million in Q1 2024, an increase of 6.2 million.
2025 年第一季 EBITDA 為 60 萬獲利,相較於 2024 年第一季虧損 500 萬,增加 560 萬。2025 年第一季淨利為 20 萬,相較於 2024 年第一季虧損 600 萬,增加 620 萬。
Diluted income per share for Q1 2025 was $0.09 compared to a loss of $2.52 per share in Q1 2024. As of the balance sheet.
2025 年第一季稀釋後每股盈餘為 0.09 美元,相較於 2024 年第一季每股虧損 2.52 美元。截至資產負債表日。
Keshikeshivalences of March 31, 2025 were 1.4 million compared to 0.9 million on December 31, 2024.
截至 2025 年 3 月 31 日的現金及約當現金為 140 萬,相較於 2024 年 12 月 31 日的 90 萬。
Total assets as of March 31, 2025 were 44,934 compared to 39,188 as of December 31st, 2024, representing an increase of 5,746 or 15%.
截至 2025 年 3 月 31 日總資產為 44,934,相較於 2024 年 12 月 31 日的 39,188,增加 5,746 或 15%。
The increase is mainly due to an increase of 2,850 in trade receivables, 2,218 in inventory, 1,031 in advance to suppliers.
該增加主要由應收帳款增加 2,850、存貨增加 2,218,以及預付供應商款項增加 1,031 所致。
Total abilities as of March 31, 2025 were 41,761 compared to 36,000 in 42 as of December 31, 2024, representing an increase of 5,719 or 16%.
截至 2025 年 3 月 31 日總負債為 41,761,相較於 2024 年 12 月 31 日的 36,000,增加 5,719 或 16%。
The company plans to finance its operation from its existing and future working capital and resources, as well as from its available credit facilities, and will continue to evaluate additional sources of capital and financing as needed.
公司計畫以現有及未來的營運資金與資源,以及可用的授信額度來支應營運,並將持續視需要評估其他資本與融資來源。
I would now like to turn the call back to you, Oren for closing remarks. Oren.
我現在想把電話交回給你,Oren,請你做結語。Oren。
Oren Shuster - Chairman, Chief Executive Officer
Oren Shuster - Chairman, Chief Executive Officer
Thank you. To sum up, Q1 2025, I'm delighted to see that the progress we have made internally, both strategically and operationally, is starting to impact the growth's financial results directly. As of this quarter, we are profitable.
謝謝。總結來說,2025 年第一季,我很高興看到我們在內部、無論在策略面或營運面所取得的進展,已開始直接反映在公司成長的財務成果上。截至本季,我們已實現獲利。
I will now end the call over to the operator to begin our question and answer session, operator.
我現在把電話交給接線員,開始我們的問答環節,接線員。
Operator
Operator
Thank you. To ask a question, please raise your hand using your mobile or desktop application or press 9 on your telephone keypad and wait for your name to be announced.
謝謝。如欲提問,請使用手機或桌面應用程式舉手,或在電話鍵盤按 9,並等待宣布您的姓名。
We have our first question from Oscar.
我們的第一個問題來自 Oscar。
Oscar
Oscar
Yes, hello? Yeah, hi.
是的,你好?嗯,嗨。
Hi, my question is, why is it important to How do I say this?
嗨,我的問題是,為什麼這很重要——我該怎麼說呢?
For the upcoming meeting of accepting the 25% of the new company. Why is that important given the given time of straight capital, why is that?
關於即將召開的會議,接受新公司 25% 的部分。在目前直接資本的時間點下,為什麼這很重要,為什麼會這樣?
Yeah, why is that important, the upcoming meeting and being approved of us approving the 25% ownership of focus.
對,為什麼這很重要——即將召開的會議,以及核准我們核准取得 Focus 25% 的持股。
Yeah, why is that point at the moment right now? Thank you.
對,為什麼這一點在此刻很重要?謝謝。
Unidentified_7
Unidentified_7
It's something that we are working on for quite some time on the regulative side and.
這是我們在監管面已經努力了一段時間的事情,而且。
It just happened now, but it's a long process. And that also, I don't know if you want to relate to that.
只是現在才發生,但這是一個漫長的流程。另外,我不知道你是否想補充說明。
Unidentified_8
Unidentified_8
Yeah, I will take it. So basically, since we are the start of companies, there are all kind of balances that we want to clear between companies and to move them from, let's call it long term loan to investment as equity. And according to tax regulations in order to do it in a In our country, you're supposed to hold 100% of the, at least for the for the focus company.
好的,我來回答。基本上,由於我們是一組公司,彼此之間有各種我們想要清理的往來餘額,並把它們從——我們稱之為——長期借款轉為以權益形式的投資。依照稅務規定,為了在我們國家這樣做,你必須持有至少 100% 的——至少就 Focus 這家公司而言。
So based on the advice we received, the best way of doing it without getting into troubles of concerning it as as revenue for tax purposes and those kind of acts from the tax authorities, we must hold 100% of the focus shares. So we had to make some kind of a deal in the And use external valuation for the value of the focus for the rest of the 26%. So we'll be able to acquire it and to be able to protect the company from a tax perspective.
因此,根據我們收到的建議,為了在不惹上麻煩、避免在稅務上被視為收入,以及避免稅務機關採取那類行動,最好的做法是我們必須持有 100% 的 Focus 股份。所以我們必須在——做某種交易,並使用外部估值來評估剩餘 26% 的 Focus 價值。如此我們才能收購它,並從稅務角度保護公司。
Oscar
Oscar
Okay.
好的。
Thank you.
謝謝。
Thank you.
謝謝。
Operator
Operator
To ask a question, please raise your hand using your mobile or desktop application and wait for your name to be announced.
如欲提問,請使用手機或桌面應用程式舉手,並等待宣布您的姓名。
There are no further questions.
沒有其他問題。
Unidentified_7
Unidentified_7
Thank you, operator and thank you all for joining our call today.
謝謝你,接線員,也謝謝各位今天參與我們的電話會議。